For the Right Perspective & Competitive Insights – Free Sample Report in Minutes in you inbox
The 120-page report analyzes the addiction therapeutics market by type (alcohol addiction therapeutics, tobacco addiction therapeutics, and drug addiction therapeutics) and geography (North America, Europe, APAC, and ROW). The report offers competitive intelligence about market leaders, key industry opportunities, trends, and threats impacting the growth of the market. Also, the report includes information on marketing, brand, strategy and market development, sales, and supply functions. Download Free Sample Report
The addictions therapeutics market is driven by the high consumption of alcohol, tobacco, and opioid products. In addition, the emergence of free state-run addiction treatment programs and facilities is anticipated to boost the growth of the addiction therapeutics market.
The market is witnessing a significant rise in the consumption of alcohol, opioids, and tobacco products despite increasing awareness and stringent regulations. According to a study, about 1 in 5 US adults were using a tobacco product in 2019, with about 80% of those adults reporting that they used combustible products such as cigarettes. The growing consumption of such products has increased the prevalence of substance use disorders globally. This is driving the demand for addiction therapeutics, which is driving the growth of the market.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Addictions Therapeutics Companies:
Alkermes Plc
Alkermes Plc operates its business through the Unified segment. The company offers VIVITROL. It is a medication used to manage alcohol or opioid dependence.
Emergent BioSolutions Inc.
Emergent BioSolutions Inc. operates its business through the Unified segment. The company offers NARCAN. It is a nasal naltrexone develop to treat alcohol use disorder.
GlaxoSmithKline Plc
GlaxoSmithKline Plc operates its business through segments such as Pharmaceuticals, Consumer healthcare, and Vaccines. The company offers Nicorette. It is a nicotine replacement therapy available in gum or lozenge form.
Indivior Plc
Indivior Plc operates its business through the Unified segment. The company develops addiction therapeutics for opioid use disorders with brand name SUBOXONE and SUBLOCADE.
Mallinckrodt Plc
Mallinckrodt Plc operates its business through segments such as Specialty Brands and Specialty Generics and Amitiza. The company develops addiction therapeutics for the maintenance treatment of opioid addiction.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Addictions Therapeutics Market Type Outlook (Revenue, USD Billion, 2020-2025)
- Alcohol - size and forecast 2020-2025
- Tobacco - size and forecast 2020-2025
- Drug - size and forecast 2020-2025
Addictions Therapeutics Market Geography Outlook (Revenue, USD Billion, 2020-2025)
- North America - size and forecast 2020-2025
- Europe - size and forecast 2020-2025
- APAC - size and forecast 2020-2025
- ROW - size and forecast 2020-2025
News Insight: https://newsroom.technavio.com/news/addictions-therapeutics-market
Related Reports on Healthcare Include:
Global Smoking Cessation and Nicotine De-Addiction Market – Global smoking cessation and nicotine de-addiction market is segmented by product (e-cigarette, NRT, and drug therapy) and geography (APAC, Europe, MEA, North America, and South America). Exclusive Free Sample Report
Global Specimen Validity Testing Market – Global specimen validity testing market is segmented by type (products and services) and geography (Asia, Europe, North America, and ROW). Exclusive Free Sample Report
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: https://www.technavio.com/report/addictions-therapeutics-market-size-industry-analysis
SOURCE Technavio
Share this article